Do mass-spectrometry-derived metabolomics improve prediction of pregnancy-related disorders? Findings from a UK birth cohort with independent validation

Share:
References: McBride N, Yousefi P, Sovio U, Taylor K, Vafai Y, Yang T, Hou B, Suderman M, Relton C, Smith GCS, Lawlor DA. Do Mass Spectrometry-Derived Metabolomics Improve the Prediction of Pregnancy-Related Disorders? Findings from a UK Birth Cohort with Independent Validation. Metabolites. 2021 Aug 10;11(8):530. doi: 10.3390/metabo11080530. PMID: 34436471; PMCID: PMC8399752.

Details:

Author(s):

Nancy McBride, Paul Yousefi, Ulla Sovio, Kurt Taylor, Yassaman Vafai, Tiffany C Yang, Bo Hou, Matthew Suderman, Caroline Relton, Gordon C. Smith, Deborah A Lawlor

Related Publications

Childhood exposure to non-persistent endocrine disruptors, glucocorticosteroids, and attentional function: A cross-sectional study based on the parametric g-formula

Overcoming doubt: developing CDoH Essentials, a practical tool to introduce the commercial determinants of health

A national survey of supervised toothbrushing programmes in England